OptiBiotix reports strong revenue growth and expands global footprint in 2024

LONDON: OptiBiotix Health plc (AIM: OPTI), a UK-based life sciences company focused on microbiome modulation and healthy sugar alternatives, reported a 35% increase in annual revenue for the year ending…

NNR June 30, 2025

London Stock Exchange

Belluscura initiates $1.5 million loan note and $12 million fundraising plan

LONDON: Belluscura plc (AIM: BELL), a UK-based medical device innovator specializing in portable oxygen enrichment technology, has launched a strategic funding initiative to strengthen its capital base and support growth.…

NNR June 30, 2025

London Stock Exchange

N4 Pharma reports 2024 financial results

LONDON: N4 Pharma plc (AIM: N4P), a UK-based biotechnology company developing its proprietary Nuvec® gene delivery system for advanced cancer and disease therapies, announced its audited financial results for the…

NNR June 6, 2025